Literature DB >> 481135

The metabolic fate of cholesterol-5 alpha, 6 alpha-expoxide in vivo.

J P Bowden, G M Muschik, J C Kawalek.   

Abstract

[14C] Cholesterol-5 alpha, 6 alpha-expoxide, administered to mice by either gastric intubation or skin painting, was rapidly and primarily excreted in the feces. Residual amonts of the epoxide and its metabolites were found in a wide variety of organs, and persisted for at least 72 hr. At some sites (principally the liver, the small intestinal contents and the combined stomach/duodenum and their contents), the labeled compound existed in a water-soluble form which could not be extracted with chloroform/methanol. Treatment of the small intestinal contents with a preparation of beta-glucuronidase/sulfatase produced a marked increase in the amount of organic-solvent-extractable cholesterol-alpha-epoxide and other polar metabolites. Unchanged epoxide was found mainly in the feces and the skin at the site of application. On the basis of these results, stool specimens, and not blood samples, should be analyzed to detect the presence of this compound and/or its metabolites in vivo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 481135     DOI: 10.1007/bf02533447

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  25 in total

1.  Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps.

Authors:  B S Reddy; E L Wynder
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  A model system for the evaluation of the role of cholesterol -oxide in ultraviolet carcinogenesis.

Authors:  H S Black; D R Douglas
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

3.  Isolation and identification of cholesterol -oxide and other minor sterols in human serum.

Authors:  M F Gray; T D Lawrie; C J Brooks
Journal:  Lipids       Date:  1971-11       Impact factor: 1.880

4.  Metabolism of cholestane-3-beta,5-alpha,6-beta-triol. I. The fate of cholestanetriol in the rat.

Authors:  H G Roscoe; R Goldstein; M J Fahrenbach
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

5.  Transformation of hamster embryo cells by cholesterol-alpha-epoxide and lithocholic acid.

Authors:  M I Kelsey; R J Pienta
Journal:  Cancer Lett       Date:  1979-03       Impact factor: 8.679

6.  Metabolic fate of epoxycholesterol in the rat.

Authors:  J A Fioriti; M J Kanuk; M George; R J Sims
Journal:  Lipids       Date:  1970-01       Impact factor: 1.880

7.  Etiologic related studies of ultraviolet light-mediated carcinogenesis.

Authors:  H S Black; J T Chan
Journal:  Oncology       Date:  1976       Impact factor: 2.935

8.  Effect of auto-oxidation products from cholesterol on aortic smooth muscle cells: an in vitro study.

Authors:  S K Peng; C B Taylor; P Tham; N T Werthessen; B Mikkelson
Journal:  Arch Pathol Lab Med       Date:  1978-02       Impact factor: 5.534

9.  Skin carcinogenesis: cholesterol-5alpha,6alpha-epoxide hydrase activity in mouse skin irradiated with ultraviolet light.

Authors:  J T Chan; H S Black
Journal:  Science       Date:  1974-12-27       Impact factor: 47.728

10.  Metabolism of cholesteryl palmitate by rat brain in vitro; formation of cholesterol epoxides and cholestane-3beta,5alpha,6beta-triol.

Authors:  C M Martin; H J Nicholas
Journal:  J Lipid Res       Date:  1973-11       Impact factor: 5.922

View more
  2 in total

1.  Analysis and physiologic significance of cholesterol epoxide in animal tissues.

Authors:  H S Black
Journal:  Lipids       Date:  1980-09       Impact factor: 1.880

2.  Cholesterol epoxide is a direct-acting mutagen.

Authors:  A Sevanian; A R Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.